Why is Link Pharma Chem falling/rising?

As of 28-Aug, Link Pharma Chem Ltd is experiencing a decline in its stock price, currently at Rs 32.66, which reflects a decrease of 2.0 (-5.77%). The stock has underperformed its sector by 4.08% today and has been on a downward trend for the last two days, accumulating a total loss of 9% during this period. The stock's performance over the past week shows a significant decline of 9.15%, and it has also underperformed in the longer term, with a year-to-date drop of 20.34%. Key negative factors contributing to this decline include weak long-term fundamentals, as evidenced by a staggering -183.49% CAGR growth in operating profits over the last five years and a poor EBIT to Interest ratio of 0.79, indicating difficulties in servicing debt. Additionally, the company reported flat results for the quarter ending June 25, with net sales and profit after tax both declining by 21.03%, further exacerbating investor concerns.
In the broader market context, the Sensex has only declined by 2.34% over the past week, highlighting that Link Pharma Chem's performance is significantly worse than the overall market. The stock's recent trading activity has been characterized by erratic patterns, including a notable drop to an intraday low of Rs 32, and a substantial decrease in delivery volume, which fell by 76.76% against the five-day average. This lack of investor participation and the stock's trading below all key moving averages suggest a bearish sentiment among investors. Overall, Link Pharma Chem's underperformance relative to the benchmark and its weak financial indicators signal a challenging environment for the stock, contributing to its current downward trajectory.